| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner, See Remarks | 10% Owner | 10% Owner, See Remarks
2 companies
Caligan Partners LP serves as a Director, 10% Owner, See Remarks at LQDA and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 27 buys and 2 sells. Those positions are worth an estimated $740.5M at current prices.
Historically, Caligan Partners LP's trades have earned a middling insider score of 58/100 across 26 rated trades. Over a 12-month horizon, 57.7% of those trades were profitable, with an average 12-month return of +4.0%.
The biggest single holding is LQDA (~$734.3M) as Director, 10% Owner, See Remarks. Net of sales, the recent Form 4 record there shows accumulation of 3,432,527 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 25, 2022 | LQDA Liquidia Corp | Director, 10% Owner, See Remarks | Buy | 79,400 | $3.40 | $269,960.00 | +0.8% | +100.0% | +139.6% | |
| May 19, 2022 | LQDA Liquidia Corp | Director, 10% Owner, See Remarks | Buy | 221,104 | $5.89 | $1,301,472.56 | +0.7% | +24.6% | +43.6% | |
| May 10, 2022 | LAB Standard Biotools Inc. | 10% Owner | Buy | 488,350 | $2.88 | $1,406,715.00 | +2.5% | -17.1% | -26.8% | |
| May 2, 2022 | LAB Standard Biotools Inc. | 10% Owner | Buy | 400,000 | $2.69 | $1,075,574.00 | +1.5% | -47.2% | -48.2% | |
| Apr 18, 2022 | LQDA Liquidia Corp | Director, 10% Owner, See Remarks | Buy | 1,764,705 | $5.10 | $8,999,995.50 | +21.2% | -27.4% | +35.8% | |
| Apr 12, 2022 | LAB Standard Biotools Inc. | 10% Owner | Buy | 195,000 | $3.80 | $741,150.00 | +1.1% | -53.2% | -50.1% | |
| Apr 8, 2022 | LAB Standard Biotools Inc. | 10% Owner | Buy | 509,573 | $3.77 | $1,922,462.80 | +2.0% | -52.1% | -52.1% |